CardioGrade, Inc. 43391 Ellsworth Street,
Suite A Fremont, CA 94539 Phone: +1 (510) 651-8010 Mark Cavanaugh, CEO +1 (510) 410- 7703 (cell phone) mcavanaugh@cardiograde.com Eva-Maria Tisdale, CFO/COO +1 (510) 366-6463 (cell phone) etisdale@cardiograde.com |
CardioGrade, Inc. was established in 2006 for the purpose of distributing state of the art Pulse Wave Technology. Although Pulse Wave measuring has been around since the 1800's, adapting it to new technology has been in development for over 10 years. The focus has been the exploration of non invasive measuring of the elasticity of the large and small vessels. In 2006 the "Cafe Study", named the "Clinical Science Paper of the Year" by the American Heart Association, determined that Central Pressure more strongly relates to vascular disease and outcome than does Brachial Pressure. Atherosclerosis starts with stiffening of the aorta! Parallel clinical studies revealed that Central Pressure can be measured with non invasive technology with 99% accuracy in comparison to the conventional Heart Catheterization. With Pulse Wave Technology the medical professional is able to measure Central Pressure and get other valuable data to identify hypertension and early stages of vascular disease. It is well known that hypertension and heart disease are the number one killer in America and worldwide. This new technology is non- invasive, low risk, accurate, repeatable, low cost, easy to administer with a cuff device. CardioGrade, Inc. has the expertise and knowledge to offer the best Pulse Wave technology presently on the market. All our technologies are FDA and CE approved.
With the acceptance and validation of Central Pressure as a more accurate measure for hypertension by medical leaders, and the addition of the specific CPT code (0133T) for insurance reimbursement, the USA market is ready to fully embrace this new technology.
With the acceptance and validation of Central Pressure as a more accurate measure for hypertension by medical leaders, and the addition of the specific CPT code (0133T) for insurance reimbursement, the USA market is ready to fully embrace this new technology.
